Purple Biotech Ltd (TLV:PPBT)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
5.20
0.00 (0.00%)
Mar 27, 2025, 4:53 PM IDT
-78.60%
Market Cap 27.54M
Revenue (ttm) n/a
Net Income (ttm) -26.37M
Shares Out 529.64M
EPS (ttm) -0.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 400,623
Average Volume 479,956
Open 5.20
Previous Close 5.20
Day's Range 5.10 - 5.40
52-Week Range 4.30 - 36.80
Beta 0.29
RSI 46.04
Earnings Date May 15, 2025

About Purple Biotech

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin recept... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1968
Employees 9
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol PPBT
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.